
Muscle is your largest glucose organ
Two people, both 48, both with a BMI of 24. One has glucose readings that behave; the other is quietly drifting towards a diabetes diagnosis. The scale cannot tell them apart, and neither can the BMI chart on the wall. The difference between them is not how much they weigh. It is what they are made of.
By the end of this article you will know where the glucose from a meal actually goes. You will see why that makes muscle a metabolic organ rather than a cosmetic one, and what to measure instead of weight.
Where does a meal’s glucose actually go?
Picture the glucose from lunch entering the blood. It needs somewhere to go, quickly. Blood can only hold about a teaspoon of glucose at any moment without damage beginning.
The brain takes a steady share. The liver and gut take a large share of a meal’s glucose on its way in. The other main destination is skeletal muscle. Under insulin’s signal, muscle is one of the main places a meal’s glucose ends its journey, and when insulin is raised in laboratory tests it takes most of it, stored there or burned as fuel.
That fact reframes a great deal. Muscle is not just what moves you. It is the body’s largest insulin-responsive glucose sink. The size of that sink decides how hard the rest of the system must work after every meal.
Which raises an uncomfortable question about the numbers we usually rely on.
Why can BMI not see the problem?
Take two people with an identical BMI of 24. One carries 30 kilograms of muscle. The other carries 22 kilograms, and correspondingly more fat. After the same meal, whose glucose rises higher?
The answer follows directly from the sink. The person with less muscle has less room to put glucose. The same meal produces a higher, longer rise, and the pancreas must make more insulin to force the smaller sink to accept it. BMI weighs the body but cannot see what it is made of. That is why it misses exactly the people whose weight looks reassuring.
This is not a rare edge case. Losing muscle while gaining fat keeps weight, and therefore BMI, almost unchanged. The chart says stable. The composition says the sink is shrinking.
And shrinking is precisely what muscle does when nothing opposes it.
What does a shrinking sink do to the labs?
From midlife onward, muscle mass declines by a few per cent per decade unless it is actively defended. Nothing about that decline announces itself. Strength fades slowly and the weight stays flat. Meanwhile the glucose numbers creep: fasting insulin first, then post-meal readings. Years later comes the fasting glucose that finally earns a diagnosis.
A shrinking muscle mass is a shrinking glucose sink, and the laboratory drift begins long before the weight changes. Read in this light, early insulin resistance in a slim, ageing person is often not a mystery. It is arithmetic.
Same meal, smaller sink, higher curve: much of what we call ageing metabolism is the quiet loss of the tissue that disposes of glucose.
The good news is that this arithmetic runs in both directions.
Why is resistance training metabolic therapy?
Most people file exercise under calories. The calorie ledger is real, but it is the least interesting thing resistance training does.
When a muscle contracts, it pulls glucose transporters to its surface and draws glucose in directly. Contracting muscle takes up glucose without waiting for insulin’s permission. A person whose insulin signalling is impaired still has a second door into their largest sink. That door is opened by nothing more sophisticated than effort.
Training then compounds the benefit twice over. Each session improves insulin sensitivity for hours to days afterwards. Over months, the muscle built enlarges the sink itself. More storage, more disposal, a calmer curve after every meal that follows.
Proven: resistance training improves insulin sensitivity and glucose control, shown repeatedly in randomised trials. Also proven: contracting muscle takes up glucose without needing insulin, an established mechanism. Strong and consistent, though observational: muscle mass and strength predict metabolic health and survival, which shows a link rather than proof of cause. Graded honestly, the practical case for building muscle is among the best-supported in metabolic medicine.
Add one question and one measurement to the metabolic assessment. Can this person rise from a chair five times without using their hands, and what is their grip strength? Both cost nothing, and both say more about the glucose sink than the weight on the scale.
- Skeletal muscle is a major destination for glucose after meals, and takes most infused glucose in laboratory insulin-clamp tests.
- BMI weighs the body but cannot see the sink, so it misses slim people with shrinking muscle.
- Muscle loss from midlife drifts the labs years before it moves the scale.
- Contracting muscle takes up glucose without insulin’s permission, which makes training a therapy, not a pastime.
- Assess strength and composition, not weight alone.
How muscle switches between burning fat and burning glucose, and why losing that flexibility is one of the earliest metabolic changes of all, is where this story goes next.
- DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32 Suppl 2:S157-S163.
- Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013;93(3):993-1017.
- Umpierre D, Ribeiro PA, Kramer CK, LeitĂŁo CB, Zucatti AT, Azevedo MJ, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790-1799.
- Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079.
- Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96(9):2898-2903.
- Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273.
- Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.
This article is educational and does not replace individual medical advice.

